information:classification, stylistic:style_transfer, linguistic:voice_change, structural:expansion
Stature

When Turner syndrome is diagnosed in early life, growth hormone therapy can decrease the degree of short stature. Treatment with human growth hormone appears to increase expected adult height by approximately 7 cm (3 in) from an otherwise expected norm of 142 cm (4 ft 8 in) – 147 cm (4 ft 10 in). The effects of growth hormone therapy are at their strongest during the first year of treatment and taper off over time. In some cases oxandrolone, a steroid with a relatively mild masculinizing effect, may be used alongside growth hormone. The addition of oxandrolone to a Turner syndrome treatment regimen adds around 2 cm (1 in) to the final height. Oxandrolone is used particularly often in girls diagnosed later in their growth period, due to the reduced impact of growth hormone alone in this population. However, oxandrolone use runs the risk of delayed breast development, voice deepening, increased body hair, or clitoromegaly.